722 results on '"Lucchinetti, Claudia F"'
Search Results
2. Teriflunomide shifts the astrocytic bioenergetic profile from oxidative metabolism to glycolysis and attenuates TNFα-induced inflammatory responses
3. Using germline variants to estimate glioma and subtype risks
4. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
5. Pathologic Factors and Spectrum of Central Nervous System Inflammatory Demyelinating Diseases
6. Fluctuating Vision Loss, Seizures, and Left Parieto-Occipital Mass
7. Biomolecular alterations detected in multiple sclerosis skin fibroblasts using Fourier transform infrared spectroscopy
8. Introduction to Thematic Reviews on Forward Thinking on Clinical Trials in Clinical Practice
9. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology
10. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
11. Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions
12. Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients
13. MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
14. ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosis
15. NEDA treatment target? No evident disease activity as an actionable outcome in practice
16. Association of Specific “Critical” Demyelinating Lesions and Motor Impairment in Progressive Multiple Sclerosis: A Prospective Study (S46.008)
17. Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis
18. Long‐term clinical, imaging and cognitive outcomes association with MS immunopathology
19. Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder
20. Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSD
21. Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
22. Population-based study of “no evident disease activity” in MS
23. Paraneoplastic neuronal intermediate filament autoimmunity
24. Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease
25. Relapses in multiple sclerosis: Relationship to disability
26. Neuromyelitis Optica Spectrum Disorder
27. Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions
28. Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica
29. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study
30. Update on pathology of central nervous system inflammatory demyelinating diseases
31. The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions
32. Multiple Sclerosis
33. Clinical Reasoning: A 50-year-old woman with SLE and a tumefactive lesion
34. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)
35. Multiple Sclerosis Pathology During Early and Late Disease Phases: Pathogenic and Clinical Relevance
36. Tumefactive Demyelination in MOG Ab–Associated Disease, Multiple Sclerosis, and AQP-4-IgG–Positive Neuromyelitis Optica Spectrum Disorder.
37. Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease.
38. Anti‐Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1
39. Tissue donations for multiple sclerosis research: current state and suggestions for improvement
40. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
41. Intractable Nausea and Vomiting From Autoantibodies Against a Brain Water Channel
42. Neuroimmunologic Mechanisms in the Etiology of Multiple Sclerosis
43. sj-docx-1-msj-10.1177_13524585221094241 – Supplemental material for The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions
44. Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders
45. Molecular outcomes of neuromyelitis optica (NMO)-lgG binding to aquaporin-4 in astrocytes
46. Taking a Microscopic Look at Multiple Sclerosis
47. Neuropathology of Multiple Sclerosis
48. Contributors
49. Immunopathology
50. Investigating the Immunopathogenic Mechanisms Underlying MOGAD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.